News Your Patients Can Use: FDA Approves Tralokinumab Autoinjector Pen for Adults With Moderate to Severe AD

June 13, 2024

AD Pipeline Watch: Sitryx Advances SYX-5219 to the Clinic

April 10, 2024

Patient Images Severely Lacking in AD Studies

April 9, 2024

New Ladder Helps Guide Choice of Non-steroidal Treatments in AD

April 7, 2024

Dr. Emma Guttman-Yassky Receives the ASA’s First-ever Therapeutic Innovation Award

April 5, 2024

Skin Biomarkers May Predict Early Risk of Food Allergies or AD in Infants; Prevention Trial Underway

March 29, 2024